步科股份(688160.SH):機器人板塊仍然是公司最看好的板塊之一
格隆匯5月27日丨步科股份(688160.SH)近日在接待機構投資者調研時表示,機器人板塊仍然是公司最看好的板塊之一。除了繼續加強公司在工業移動機器人(AGV/AMR)的領先優勢外,公司重點關注能夠帶來批量訂單的下游機器人市場,如協作機器人、工業4/6軸機械臂等市場。2023年,公司針對協作機器人方向設計的無框力矩電機產品出貨量實現翻倍增長,未來,公司認為協作機器人具有較大的發展空間,會成為公司在機器人行業的重要增長點之一。在工業4/6軸機械臂方向,公司經過兩年的深耕,與核心客户形成明確的合作意向,預計今年將會形成批量訂單的交付。除此之外,公司也會持續關注服務機器人、特種機器人、仿生機器人等方向的發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.